您的位置: 首页 > 农业专利 > 详情页

Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitor
专利权人:
エナンタ ファーマシューティカルズ インコーポレイテッド
发明人:
オア,ヤット,サン,ムーア,ジョエル,ディー.,リウ,ドン,スン,イン,ガイ,ヨンファ,タン,ダートン,ニウ,デチアン,シー,グオヨウ,ワン,チョー,オア,ヤット,サン,ムーア,ジョエル,ディー.,リウ,ドン,スン,イン,ガイ,ヨンファ,タン,ダートン,ニウ,デチアン,シー,グオヨウ,ワン,チョー
申请号:
JP2009518517
公开号:
JP5520046B2
申请日:
2007.06.26
申请国别(地区):
JP
年份:
2014
代理人:
摘要:
The present invention relates to compounds, including compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充